October 2, 2026
Announcement
| ALCON INC |
| ALK-ABELLO A/S |
| BAVARIAN NORDIC A/S |
| COLOPLAST AS CLASS B |
| CONVATEC GROUP PLC |
| DR SULAIMAN AL HABIB MEDICAL SERVICES GROUP CO |
| FRESENIUS MEDICAL CARE AG & CO KGAA |
| FRESENIUS N |
| GALDERMA GROUP AG |
| GENMAB A/S |
| GETINGE AB CLASS B |
| GRIFOLS SA CLASS A |
| GSK PLC |
| HALEON PLC |
| HIKMA PHARMACEUTICALS PLC |
| INTERNATIONAL HOLDINGS CO PJSC |
| KONINKLIJKE PHILIPS NV |
| LABORATORIOS FARMACEUTICOS R |
| LONZA GROUP AG |
| MERCK KGAA |
| MOUWASAT MEDICAL |
| NOVARTIS AG |
| RECORDATI SPA |
| RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT |
| ROCHE HOLDING AG |
| SANDOZ GROUP AG |
| SANOFI SA |
| SAUDI PHARMACEUTICAL INDUSTR |
| SIEGFRIED HOLDING AG-REG |
| SIEMENS HEALTHINEERS AG |
| SMITH & NEPHEW PLC |
| SONOVA HOLDING AG |
| SWEDISH ORPHAN BIOVITRUM AB |
| YPSOMED HOLDING AG |
We work closely with our internal partners to deliver investment ideas that generate demonstrable value for our clients.